NIHR BioResource published new discoveries into Crohn's disease, immune disorders, and frontotemporal dementia with the MRC Laboratory of Molecular Biology and University of Cambridge.

The NIHR BioResource for Translational Research in Common and Rare Diseases - NIHR BioResource thereafter - is at the heart of improving healthcare and the long-term prevention and treatment of disease. The NIHR BioResource is committed to bringing together volunteers, researchers, clinicians, patient groups, charities and companies to contribute to leading research that benefits all. We have built a national resource that supports participation of members of the public in health research, catalysing innovative medical research and clinical trials through the improvement of diagnosis and treatment of diseases. We bring people together and lead research to help scientific discoveries to move more quickly from the lab to the patient. The children, young people and adults who take part in the NIHR BioResource are vital to our role in experimental medicine and clinical research. They provide a biological sample and let us access their health-related records to help us better understand disease. They are willing to take part in research and may be healthy or living with a common or rare disease condition. With a particular focus on phenotype or genotype, we help research organisations with their research studies and clinical trials, by either participant recall or the provision of data and/or biological samples. The uniqueness of our volunteer panel has already enabled researchers from around the world to make significant research and clinical discoveries. We are funded by the National Institute for Health and Care Research (NIHR) – the nation's largest funder of health and social care research – which is funded largely by the Department for Health and Social Care in England. For more information on the NIHR, please visit www.nihr.ac.uk